Christopher Dell Insider Profile
4 Followers
Christopher Dell, Vice-President of Business Development at HLS Therapeutics Inc, holds 100.00K shares in HLS Therapeutics Inc (Ticker: TSE:HLS). Most recently, Christopher Dell Sold 14,700 shares of HLS Therapeutics Inc on Dec 03, 2015 for an estimated value of C$36.75K.
Christopher Dell's Trading History
| HLSHLS Therapeutics Inc | Dec 03, 2015 | Vice-President of Business Development | Informative Sell | 36.75K | C$371.00K | |||||||||||||||||||||||||||||||||||||||||||
TSE:HLS Insider Shares: 100.00K (73.49%)
| ||||||||||||||||||||||||||||||||||||||||||||||||
You May Also Like
Christopher Dell insider profile FAQ
What is the percentage of profitable transactions made by Christopher Dell?
The percentage of profitable transactions made by Christopher Dell is 100%.
What is the average return per transaction made by Christopher Dell?
The average return per transaction made by Christopher Dell is 1.10%.
What stocks does Christopher Dell hold?
Christopher Dell holds: TSE:HLS stocks.
What was Christopher Dell’s latest transaction?
Christopher Dell’s latest transaction was an Informative Sell of C$36.75K.
What was Christopher Dell's most profitable transaction?
Christopher Dell’s most profitable transaction was an Informative Sell of TSE:HLS stock on November 25, 2015. The return on the trade was 1.70%.
What is Christopher Dell's role in HLS Therapeutics Inc?
Christopher Dell's role in HLS Therapeutics Inc is Vice-President of Business Development.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
